Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...
A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...
A Trump administration order to freeze communication at the National Institutes of Health has disrupted scientific research ...
A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.
The Trump administration has appointed Matthew Memoli, a veteran researcher who was critical of the U.S. response to the ...
Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...
Princeton received fewer awards in the past two fiscal years of 2023 and 2024 than in every year since 2011 and less funding ...
Matthew Memoli, a National Institute of Allergy and ... hasn’t been scheduled yet. Though Memoli is an NIH insider, one source familiar with him noted his perspectives —particularly his ...
Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as ...